Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchSpecialized Academic Departments and Institutes
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Sunnybrook Health Sciences Centre

Canada
6 Trials

Major academic hospital in Toronto affiliated with the University of Toronto. Contributes to Canadian psychedelic research through its Odette Cancer Centre's involvement in psilocybin trials for cancer-related distress, and its Department of Psychiatry's participation in CANMAT task forces on psychedelic treatments for depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

6

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Canada
Website
Visit

Sponsored Trials

4
Not yet recruitingIII

Intravenous ketamine and immersive virtual reality to treat depression (TREASURE)

Start Date
Compounds
Ketamine
RecruitingII

A Randomized Neuroimaging Trial of Psilocybin in Depression

Start Date
Compounds
Psilocybin, Placebo
Completed

Chart Review of Patients Undergoing Ketamine Treatments for Depression

Start Date
Compounds
Ketamine
CompletedI

Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression

Start Date
Compounds
Ketamine, Placebo

Collaborated Trials

2
Not yet recruitingI, II

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Start Date
Compounds
Ketamine
RecruitingII

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Start Date
Compounds
Psilocybin, Placebo